Arcutis Biotherapeutics, Inc. (ARQT)
24.60
+1.37
(+5.90%)
USD |
NASDAQ |
Jun 11, 16:00
24.60
0.00 (0.00%)
After-Hours: 19:31
Arcutis Biotherapeutics Max Drawdown (5Y) : 95.02% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 95.02% |
| April 30, 2026 | 95.02% |
| March 31, 2026 | 95.02% |
| February 28, 2026 | 95.02% |
| January 31, 2026 | 95.02% |
| December 31, 2025 | 95.02% |
| November 30, 2025 | 95.02% |
| October 31, 2025 | 95.02% |
| September 30, 2025 | 95.02% |
| August 31, 2025 | 95.02% |
| July 31, 2025 | 95.02% |
| June 30, 2025 | 95.02% |
| May 31, 2025 | 95.02% |
| April 30, 2025 | 95.02% |
| March 31, 2025 | 95.02% |
| February 28, 2025 | 95.02% |
| January 31, 2025 | 95.02% |
| December 31, 2024 | 95.02% |
| November 30, 2024 | 95.02% |
| October 31, 2024 | 95.02% |
| September 30, 2024 | 95.02% |
| August 31, 2024 | 95.02% |
| July 31, 2024 | 95.02% |
| June 30, 2024 | 95.02% |
| May 31, 2024 | 95.02% |
| Date | Value |
|---|---|
| April 30, 2024 | 95.02% |
| March 31, 2024 | 95.02% |
| February 29, 2024 | 95.02% |
| January 31, 2024 | 95.02% |
| December 31, 2023 | 95.02% |
| November 30, 2023 | 95.02% |
| October 31, 2023 | 93.92% |
| September 30, 2023 | 85.64% |
| August 31, 2023 | 80.33% |
| July 31, 2023 | 79.69% |
| June 30, 2023 | 79.69% |
| May 31, 2023 | 79.69% |
| April 30, 2023 | 72.34% |
| March 31, 2023 | 72.34% |
| February 28, 2023 | 63.41% |
| January 31, 2023 | 63.41% |
| December 31, 2022 | 62.25% |
| November 30, 2022 | 61.11% |
| October 31, 2022 | 61.11% |
| September 30, 2022 | 61.11% |
| August 31, 2022 | 61.11% |
| July 31, 2022 | 61.11% |
| June 30, 2022 | 61.11% |
| May 31, 2022 | 61.11% |
| April 30, 2022 | 61.11% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Incyte Corp. | 58.51% |
| MannKind Corp. | 69.35% |
| PTC Therapeutics, Inc. | 73.78% |
| Capricor Therapeutics, Inc. | 91.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -23.63 |
| Beta (5Y) | 1.514 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 90.16% |
| Historical Sharpe Ratio (5Y) | -0.0837 |
| Historical Sortino (5Y) | -0.172 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.31% |